Jan Hennigs
Dr. med.
Jan K. Hennigs
  • Assistant physician
Working area

Contact

Languages
German (Mother tongue)
English

Areas of expertise

Awards

Memberships

Publications

Zurück
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2008
Vor

The P2-receptor-mediated Ca2+ signalosome of the human pulmonary endothelium - implications for pulmonary arterial hypertension
Hennigs J, Lüneburg N, Stage A, Schmitz M, Körbelin J, Harbaum L, Matuszcak C, Mienert J, Bokemeyer C, Böger R, Kiefmann R, Klose H
PURINERG SIGNAL. 2019 [Epub ahead of print].

PPARγ Interaction with UBR5/ATMIN Promotes DNA Repair to Maintain Endothelial Homeostasis
Li C, Mahon C, Sweeney N, Verschueren E, Kantamani V, Li D, Hennigs J, Marciano D, Diebold I, Abu-Halawa O, Elliott M, Sa S, Guo F, Wang L, Cao A, Guignabert C, Sollier J, Nickel N, Kaschwich M, Cimprich K, Rabinovitch M
CELL REP. 2019;26(5):1333-1343.e7.

Smooth Muscle Contact Drives Endothelial Regeneration by BMPR2-Notch1-Mediated Metabolic and Epigenetic Changes
Miyagawa K, Shi M, Chen P, Hennigs J, Zhao Z, Wang M, Li C, Saito T, Taylor S, Sa S, Cao A, Wang L, Snyder M, Rabinovitch M
CIRC RES. 2019;124(2):211-224.

Role of Toll-like receptors and interferon regulatory factors in different experimental heart failure models of diverse etiology: IRF7 as novel cardiovascular stress-inducible factor
Becher P, Hinrichs S, Fluschnik N, Hennigs J, Klingel K, Blankenberg S, Westermann D, Lindner D
PLOS ONE. 2018;13(3):e0193844.

Schistosomiasis bei Flüchtlingen und Migranten
Hennigs A, Hennigs J, Schmiedel S
Flug-Tropen-Reisemedizin. 2018;25(01):19-22.

Myeloperoxidase aggravates pulmonary arterial hypertension by activation of vascular Rho-kinase
Klinke A, Berghausen E, Friedrichs K, Molz S, Lau D, Remane L, Berlin M, Kaltwasser C, Adam M, Mehrkens D, Mollenhauer M, Manchanda K, Ravekes T, Heresi G, Aytekin M, Dweik R, Hennigs J, Kubala L, Michaëlsson E, Rosenkranz S, Rudolph T, Hazen S, Klose H, Schermuly R, Rudolph V, Baldus S
JCI Insight. 2018;3(11):.

Pathobiology, pathology and genetics of pulmonary hypertension: Update from the Cologne Consensus Conference 2018
Olschewski A, Berghausen E, Eichstaedt C, Fleischmann B, Grünig E, Grünig G, Hansmann G, Harbaum L, Hennigs J, Jonigk D, Kuebler W, Kwapiszewska G, Pullamsetti S, Stacher E, Weissmann N, Wenzel D, Schermuly R
INT J CARDIOL. 2018;272S(S1):4-10.

Amphetamines promote mitochondrial dysfunction and DNA damage in pulmonary hypertension
Chen P, Cao A, Miyagawa K, Tojais N, Hennigs J, Li C, Sweeney N, Inglis A, Wang L, Li D, Ye M, Feldman B, Rabinovitch M
JCI Insight. 2017;2(2):e90427.

Monitoring und Individualisierung von körperlichem Training bei Patienten mit pulmonaler Hypertonie
Harbaum L, Grimminger J, Galow S, Grünig E, Klose H, Hennigs J
Der Pneumologe. 2017;14(4):237-243.

Upregulation of Human Endogenous Retrovirus-K Is Linked to Immunity and Inflammation in Pulmonary Arterial Hypertension
Saito T, Miyagawa K, Chen S, Tamosiuniene R, Wang L, Sharpe O, Samayoa E, Harada D, Moonen J, Cao A, Chen P, Hennigs J, Gu M, Li C, Leib R, Li D, Adams C, Del Rosario P, Bill M, Haddad F, Montoya J, Robinson W, Fantl W, Nolan G, Zamanian R, Nicolls M, Chiu C, Ariza M, Rabinovitch M
CIRCULATION. 2017;136(20):1920-1935.

Acute effects of exercise on the inflammatory state in patients with idiopathic pulmonary arterial hypertension
Harbaum L, Renk E, Yousef S, Glatzel A, Lüneburg N, Hennigs J, Oqueka T, Baumann H, Atanackovic D, Grünig E, Böger R, Bokemeyer C, Klose H
BMC PULM MED. 2016;16(1):145.

In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug
Hopper R, Moonen J, Diebold I, Cao A, Rhodes C, Tojais N, Hennigs J, Gu M, Wang L, Rabinovitch M
CIRCULATION. 2016;133(18):1783-94.

Aktuelle Evidenz bei pulmonal arterieller Hypertonie: Diagnose- und Therapieleitfaden
Klose H, Hennigs J, Harbaum L, Simon M, Oqueka T, Sydow K
2016. Aktuelle Evidenz bei pulmonal arterieller Hypertonie . Klose H (eds.). 3. ed. 1-68.

Pathobiologie, Pathologie und Genetik der pulmonalen Hypertonie: Empfehlungen der Kölner Konsensus-Konferenz 2016
Olschewski A, Berghausen E, Eichstaedt C, Fleischmann B, Grünig E, Grünig G, Hansmann G, Harbaum L, Hennigs J, Jonigk D, Kübler W, Kwapiszewska G, Pullamsetti S, Stacher E, Weissmann N, Wenzel D, Schermuly R
DEUT MED WOCHENSCHR. 2016;141(S 01):S4-S9.

Increased Pyruvate Dehydrogenase Kinase 4 Expression in Lung Pericytes Is Associated with Reduced Endothelial-Pericyte Interactions and Small Vessel Loss in Pulmonary Arterial Hypertension
Yuan K, Shao N, Hennigs J, Discipulo M, Orcholski M, Shamskhou E, Richter A, Hu X, Wu J, de Jesus Perez V
AM J PATHOL. 2016;186(9):2500-14.

BMPR2 preserves mitochondrial function and DNA during reoxygenation to promote endothelial cell survival and reverse pulmonary hypertension
Diebold I, Hennigs J, Miyagawa K, Li C, Nickel N, Kaschwich M, Cao A, Wang L, Reddy S, Chen P, Nakahira K, Alcazar M, Hopper R, Ji L, Feldman B, Rabinovitch M
CELL METAB. 2015;21(4):596-608.

Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a murine model of Marfan syndrome
Emrich F, Okamura H, Dalal A, Penov K, Merk D, Raaz U, Hennigs J, Chin J, Miller M, Pedroza A, Craig J, Koyano T, Blankenberg F, Connolly A, Mohr F, Alvira C, Rabinovitch M, Fischbein M
ARTERIOSCL THROM VAS. 2015;35(1):146-54.

Does Circulating IL-17 Identify a Subset of Patients With Idiopathic Pulmonary Arterial Hypertension?
Harbaum L, Oqueka T, Glatzel A, Hennigs J, Lüneburg N, Klose H
CHEST. 2015;148(4):e131-2.

Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling
Nickel N, Spiekerkoetter E, Gu M, Li C, Li H, Kaschwich M, Diebold I, Hennigs J, Kim K, Miyagawa K, Wang L, Cao A, Sa S, Jiang X, Stockstill R, Nicolls M, Zamanian R, Bland R, Rabinovitch M
AM J RESPIR CRIT CARE MED. 2015;191(11):1273-86.

Transcription Factor Runx2 Promotes Aortic Fibrosis and Stiffness in Type 2 Diabetes Mellitus
Raaz U, Schellinger I, Chernogubova E, Warnecke C, Kayama Y, Penov K, Hennigs J, Salomons F, Eken S, Emrich F, Zheng W, Adam M, Jagger A, Nakagami F, Toh R, Toyama K, Deng A, Buerke M, Maegdefessel L, Hasenfuß G, Spin J, Tsao P
CIRC RES. 2015;117(6):513-24.

RNA Sequencing Analysis Detection of a Novel Pathway of Endothelial Dysfunction in Pulmonary Arterial Hypertension
Rhodes C, Im H, Cao A, Hennigs J, Wang L, Sa S, Chen P, Nickel N, Miyagawa K, Hopper R, Tojais N, Li C, Gu M, Spiekerkoetter E, Xian Z, Chen R, Zhao M, Kaschwich M, Del Rosario P, Bernstein D, Zamanian R, Wu J, Snyder M, Rabinovitch M
AM J RESPIR CRIT CARE MED. 2015;192(3):356-66.

Intrinsic BMP Antagonist Gremlin-1 as a Novel Circulating Marker in Pulmonary Arterial Hypertension
Wellbrock J, Harbaum L, Stamm H, Hennigs J, Schulz B, Klose H, Bokemeyer C, Fiedler W, Lüneburg N
LUNG. 2015.

Complete resolution of idiopathic pulmonary arterial hypertension following chemotherapy
Harbaum L, Hennigs J, Baumann H, Bokemeyer C, Olschewski H, Klose H
EUR RESPIR J. 2014;43(5):1513-5.

N-terminal pro-brain natriuretic Peptide is a useful prognostic marker in patients with pre-capillary pulmonary hypertension and renal insufficiency
Harbaum L, Hennigs J, Baumann H, Lüneburg N, Griesch E, Bokemeyer C, Grünig E, Klose H
PLOS ONE. 2014;9(4):e94263.

Fibrinogen plasma concentration is an independent marker of haemodynamic impairment in chronic thromboembolic pulmonary hypertension
Hennigs J, Baumann H, Lüneburg N, Quast G, Harbaum L, Heyckendorf J, Sydow K, Schulte-Hubbert B, Halank M, Klose H
SCI REP-UK. 2014;4:4808.

Loss of somatostatin receptor subtype 2 in prostate cancer is linked to an aggressive cancer phenotype, high tumor cell proliferation and predicts early metastatic and biochemical relapse
Hennigs J, Müller J, Adam M, Spin J, Riedel E, Graefen M, Bokemeyer C, Sauter G, Huland H, Schlomm T, Minner S
PLOS ONE. 2014;9(7):e100469.

The endothelial ADMA/NO pathway in hypoxia-related chronic respiratory diseases
Lüneburg N, Harbaum L, Hennigs J
BIOMED RES INT . 2014;2014:501612.

Hamburger Netzwerk Pulmonale Hypertonie
Harbaum L, Hennigs J, Baumann H, Lüneburg N, Kluge S, Weil J, Sydow K, Klose H
Hamb Ärztebl. 2013;(10):26-28.

Low intensity, long-term outpatient rehabilitation in COPD: a randomised controlled trial.
Baumann H, Kluge S, Rummel K, Klose H, Hennigs J, Schmoller T, Meyer A
RESP RES. 2012;13:86.

Fiber optic bronchoscopy in patients with acute hypoxemic respiratory failure requiring noninvasive ventilation--a feasibility study.
Baumann H, Klose H, Simon M, Ghadban T, Braune S, Hennigs J, Kluge S
CRIT CARE. 2011;15(4):179.

Klassifikation und Differentialdiagnose der pulmonalen Hypertonie
Hennigs J, Baumann H, Lüneburg N, Kluge S, Sydow K, Klose H
Atemwegs LungenKh. 2011;37:443-448.

Characterization of Enterobacter cloacae pneumonia: a single-center retrospective analysis
Hennigs J, Baumann H, Schmiedel S, Tennstedt P, Sobottka I, Bokemeyer C, Kluge S, Klose H
LUNG. 2011;189(6):475-83.

Characterization of Enterobacter cloacae pneumonia: a single-center retrospective analysis.
Hennigs J, Baumann H, Schmiedel S, Tennstedt P, Sobottka I, Bokemeyer C, Kluge S, Klose H
LUNG. 2011;189(6):475-483.

Molecular basis of P2-receptor-mediated calcium signaling in activated pancreatic stellate cells.
Hennigs J, Seiz O, Spiro J, Berna M, Baumann H, Klose H, Pace A
PANCREAS. 2011;40(5):740-746.

Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?
Hennigs J, von Amsberg G, Baumann H, Honecker F, Kluge S, Bokemeyer C, Brümmendorf T, Klose H
BMC PULM MED. 2011;11:30.

Der Stellenwert von aktiviertem Protein C und Immunglobulinen in der Sepsistherapie
Hennigs J, Baumann H, Klose H, Kluge S
Atemwegs LungenKh. 2010;36:405-412.

Sweet taste receptor interacting protein CIB1 is a general inhibitor of InsP3-dependent Ca2+ release in vivo.
Hennigs J, Burhenne N, Stähler F, Winnig M, Walter B, Meyerhof W, Schmale H
J NEUROCHEM. 2008;106(5):2249-2262.

Letzte Aktualisierung aus dem FIS: 18.08.2019 - 05:14 Uhr